Detalhe da pesquisa
1.
Immune response to ART initiation in advanced HIV infection.
HIV Med
; 24(6): 716-726, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792544
2.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV Med
; 24(1): 27-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35527425
3.
Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study.
J Antimicrob Chemother
; 78(1): 161-168, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322475
4.
Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens.
AIDS Care
; 34(3): 404-407, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125632
5.
Differential detection of M184V/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCs.
J Antimicrob Chemother
; 75(8): 2249-2252, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32413134
6.
EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water.
AIDS Res Hum Retroviruses
; 39(1): 38-43, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301928
7.
Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens.
Open Forum Infect Dis
; 9(3): ofac018, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169590
8.
High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I.
AIDS
; 36(11): 1511-1520, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35466963
9.
Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
J Acquir Immune Defic Syndr
; 86(4): 490-495, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315694
10.
Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.
J Acquir Immune Defic Syndr
; 88(4): 393-398, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506342
11.
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial.
Infect Dis Ther
; 10(2): 775-788, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686573
12.
Etravirine and rilpivirine: nonnucleoside reverse transcriptase inhibitors with activity against human immunodeficiency virus type 1 strains resistant to previous nonnucleoside agents.
Pharmacotherapy
; 29(3): 281-94, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19249947
13.
Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial.
Lancet HIV
; 6(10): e655-e666, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578954
14.
Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database.
Am J Health Syst Pharm
; 75(15): 1132-1139, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903710
15.
A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients.
Pharmacotherapy
; 37(12): 1498-1506, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023938
16.
On the horizon: promising investigational antiretroviral agents.
Curr Pharm Des
; 12(9): 1091-103, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16515488
17.
Drug Interactions with Cobicistat- or Ritonavir-Boosted Elvitegravir.
AIDS Rev
; 18(2): 101-11, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27196356
18.
Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr
; 69(4): 493-8, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886923
19.
Enfuvirtide: first fusion inhibitor for treatment of HIV infection.
Am J Health Syst Pharm
; 61(12): 1242-7, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15259753
20.
Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection.
J Am Geriatr Soc
; 62(3): 447-53, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576251